To exclude that the reduced B lymphocyte proliferation might be due to a CAR-Treg reprogramming and consequent B-cell killing, we co-cultured ALL-CM, a CD19+ cell line, with either 19CAR-Tregs, 19CAR-Tconvs or UT-Tconvs. The gene discussed is CD19; the disease is acute lymphoblastic leukemia.